Filing metadata

Accession number
0000899243-22-018594
Form type
Form 4
Filer
BridgeBio Pharma, Inc.
CIK
CIK 1743881
Filed
May 18, 2022
Reporting period
May 16, 2022
Description
Insider transaction

Explore SEC Filings Hub